Stratasys and Ricoh USA have enrolled the first patient in a clinical study to assess 3D printed models for preoperative planning in orthopaedic oncology.

The research aims to compare 3D printed anatomical models’ efficacy against the current standard of care, which involves CT or MRI imaging, to potentially improve surgical outcomes.

As part of the study, the companies will assess if the use of these models can lead to reduced operating times, less blood loss, and a decrease in procedural complications.

The experimental group will use the 3D-printed models alongside imaging while the comparator group will rely solely on imaging for their preoperative planning.

Stratasys Medical vice-president Erez Ben Zvi said: “The collaboration brings together unparalleled experience and innovation in medical imaging and 3D printing and, if successful, may establish anatomical models as a new standard for patient treatment in tumour removal from bones.”

Scheduled for a 12-month period, the prospective, multi-centre randomised controlled study involves up to 150 subjects at three different sites.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The Ohio State University Wexner Medical Center and Corewell Health have already agreed to participate.

Ricoh USA Additive Manufacturing managing director Gary Turner said: “We are thrilled to co-sponsor this important clinical trial alongside our longstanding partners at Stratasys to further demonstrate the potential impact of 3D patient-specific modelling, as well as accelerate the adoption of this technology to better serve a broader population.”

Earlier this month, Ricoh USA unveiled its Point of Care 3D medical device manufacturing facility in the US.

Located in Winston-Salem, North Carolina, the RICOH 3D for Healthcare Innovation Studio will provide clinicians with immediate access to 3D-printed anatomic models for surgical planning and patient education.